Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Vsee Health Q3 2026 Results: Net Loss of $2.85M, Loss Widens

VSee Health, Inc. reported total revenues of $4.94 million for the nine months ended September 30, 2026, a slight increase from $4.57 million in the prior year. The company experienced a net loss of $4.60 million for the period, which was an improvement over the $6.86 million net loss reported in 2025, primarily due to income from discontinued operations.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1.52.3
Gross profit0.31.1
Profit before tax-2.8-0.0
Net income-2.8-0.3

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-35.5%
Gross margin20.8%
Operating margin-145.0%
Source

10-Q filed with the SEC, OTC: VSEE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Vsee Health, Inc.: key numbers

Share price
$0.2900Close, Nov 16
Market cap
$254K
Shares outstanding
876.84KLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Health ServicesSIC 8000

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Vsee Health, Inc.

All →
4:15 PM ET 8-K
Loan & Debt

Vsee Health Debt Financing Update with Vanquish

VSee Health issued an additional unsecured convertible promissory note to Vanquish in the principal amount of $180,550, which includes an original issue discount. The note carries a one-time 12% interest charge and is convertible into common stock only upon an event of default at a 35% discount to the market price.

Counterparty
Vanquish
Term
through July 30, 2027
4:11 PM ET 8-K
Reverse Stock Split

Vsee Health Reverse Stock Split

VSee Health, Inc. has filed a Certificate of Amendment to effect a 1-for-80 reverse stock split of its common stock, effective September 23, 2026. The stock will begin trading on a split-adjusted basis on September 24, 2026, under a new CUSIP number. No fractional shares will be issued, with any resulting fractions rounded up to the next whole number.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.